Skip to main content
. 2015 Apr 3;123(10):1038–1045. doi: 10.1289/ehp.1408834

Table 2.

Maternal blood TG and FA levels in relation to the characteristics of the mother–infant pairs (= 306).

Characteristic n TG(mg/dL) Palmitic acid (μg/mL) Palmitoleic acid (μg/mL) Stearic acid (μg/mL) Oleic acid (μg/mL) Linoleic acid(μg/mL) α‑Linolenic acid (μg/mL) Arachidonic acid (μg/mL) EPA(μg/mL) DHA (μg/mL)
All samples 306 90.8 ± 46.1 2064.8 ± 858.8 126 ± 78.5 573.1 ± 206.3 1214.5 ± 564.5 721.2 ± 419.7 10.7 ± 8.3 71.2 ± 42.4 10.2 ± 8.4 30.2 ± 21.6
Maternal characteristics
Paritya,b
0 161 88.5 ± 3.6 2063.0 ± 67.8 123.4 ± 6.2 582.0 ± 16.2 1207.4 ± 44.6 711.9 ± 33.1 10.5 ± 0.6 71.0 ± 3.3 10.1 ± 0.6 29.0 ± 1.7
≥ 1 144 92.7 ± 3.8 2070.1 ± 71.7 129.2 ± 6.5 564.5 ± 17.2 1223.5 ± 47.1 729.7 ± 35.0 10.9 ± 0.6 71.4 ± 3.5 10.2 ± 0.7 31.4 ± 1.8
Smoking during pregnancya
Yes 130 95.7 ± 4.0 2121.9 ± 75.3 133.3 ± 6.8 563.5 ± 18.1 1268.9 ± 49.4 740.5 ± 36.8 10.9 ± 0.7 69.0 ± 3.7 9.1 ± 0.7 27.4 ± 1.8
No 176 87.1 ± 3.4 2022.6 ± 64.7 120.6 ± 5.9 580.2 ± 15.5 1174.4 ± 42.4 707.0 ± 31.6 10.6 ± 0.6 72.8 ± 3.1 11.0 ± 0.6 32.2 ± 1.6
Alcohol intake during pregnancya
Yes 97 83.8 ± 4.6 2020.1 ± 87.2 118.4 ± 7.9 573.7 ± 20.9 1200.5 ± 57.4 745.0 ± 42.6 11.4 ± 0.8 75.2 ± 4.3 10.2 ± 0.8 32.2 ± 2.2
No 209 94.0 ± 3.1* 2085.6 ± 59.4 129.5 ± 5.4 572.8 ± 14.2 1221.0 ± 39.1 710.2 ± 29.0 10.4 ± 0.5 69.4 ± 2.9 10.2 ± 0.5 29.3 ± 1.5
Fish intake during pregnancya
Inshore fish
≤ 1–2 times/month 166 91.0 ± 3.5 2054.1 ± 66.7 127.6 ± 6.1 566.3 ± 16.0 1217.7 ± 43.8 708.5 ± 32.6 10.2 ± 0.64 71.8 ± 3.2 8.8 ± 0.64 28.6 ± 1.6
≥ 1–2 times/week 140 90.5 ± 3.9 2077.5 ± 72.6 124.0 ± 6.6 581.1 ± 17.4 1210.8 ± 47.7 736.4 ± 35.5 11.3 ± 0.70 70.5 ± 3.5 11.8 ± 0.7** 32.1 ± 1.8
Deep-sea fish
≤ 1–2 times/month 148 91.6 ± 3.7 2114.6 ± 70.5 132.9 ± 6.4 586.9 ± 16.9 1248.7 ± 46.4 723.7 ± 34.5 10.7 ± 0.6 72.0 ± 3.4 9.8 ± 0.6 28.8 ± 1.7
≥ 1–2 times/week 158 90.0 ± 3.6 2018.1 ± 68.3 119.5 ± 6.2 560.2 ± 16.4 1182.5 ± 44.9 718.9 ± 33.4 10.7 ± 0.6 70.5 ± 3.3 10.5 ± 0.6 31.5 ± 1.7
Blood sampling period (categorical)c
23–31 weeks during pregnancy 137 81.2 ± 3.8 1928.7 ± 72.7 110.7 ± 6.6 562.7 ± 17.4 1095.8 ± 47.3 686.3 ± 35.8 10.3 ± 0.7 70.9 ± 3.5 10.5 ± 0.7 32.3 ± 1.8
32–34 weeks during pregnancy 82 93.5 ± 5.0 2107.2 ± 94.0 129.5 ± 8.5 624.2 ± 22.5 1252.1 ± 61.2 726.6 ± 46.3 10.9 ± 0.9 80.1 ± 4.6 10.1 ± 0.9 32.0 ± 2.3
35–41 weeks during pregnancy 87 103.2 ± 4.8** 2239.2 ± 91.2* 146.7 ± 8.2* 541.2 ± 21.9** 1366.2 ± 59.4** 771.3 ± 44.9 11.1 ± 0.8 63.4 ± 4.5 9.7 ± 0.9 25.2 ± 2.3*
Blood sampling period (week of pregnancy)d 306 ρ = 0.198** ρ = 0.176** ρ = 0.208** ρ = 0.055 ρ = 0.223** ρ = 0.086 ρ = 0.035 ρ = –0.042 ρ = –0.009 ρ = –0.122*
Infant characteristics
Birth weightd 306 ρ = –0.007 ρ = –0.055 ρ = –0.076 ρ = –0.074 ρ = –0.011 ρ = 0.021 ρ = –0.022 ρ = 0.010 ρ = 0.052 ρ = 0.031
Abbreviations: DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; TG, triglyceride. Data are means ± SD or correlations unless otherwise indicated.*p < 0.05. **p < 0.01. p-Values were calculated by aMann–Whitney U-test, cKruskal–Wallis test, or dSpearman’s correlation (ρ); bmissing data: parity (n = 1);